News

InvestorsHub on MSN4d

Nyxoah Shares Climb Following FDA Clearance of Genio Device for Sleep Apnea Treatment

Nyxoah SA (NASDAQ:NYXH) saw its stock rise 9.4% after the FDA granted approval for its Genio system designed to treat ...
Zacks.com on MSN22h

Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea

NYXH wins FDA approval for its leadless, battery-free Genio sleep apnea therapy, backed by strong trial results.
The College Fix1d

Tech expert to universities: Yes, it’s time to integrate AI — here’s how

“AI can be used as a gym – a place for training, challenge, and growth – or as a diet pill, a way to bypass effort in the ...
Pulmonology Advisor3d

FDA Clears Genio System for Obstructive Sleep Apnea

The FDA has approved the Genio system for the treatment of patients with moderate to severe obstructive sleep apnea.
MobiHealthNews3d

Nyxoah gets FDA clearance for sleep apnea device Genio

Nyxoah is in the midst of a lawsuit brought on by Inspire Medical Systems alleging infringement of several patents related to its recently-cleared offering, Genio.
Medical Dialogues2d

FDA Approves Genio® System for Moderate to Severe OSA

The FDA has approved the Genio® system for treating patients with moderate to severe obstructive sleep apnea (OSA) with an ...

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

Genio is a different approach to hypoglossal nerve stimulation (HGNS) for the treatment of OSA. Genio’s unique design ...
MassDevice7d

Nyxoah wins FDA nod for sleep apnea neuromod system

Nyxoah announced today that it received FDA approval for its Genio neuromodulation device for treating sleep apnea.
Monthly Prescribing Reference5d

FDA Clears Genio System for Obstructive Sleep Apnea

The Food and Drug Administration (FDA) has approved the Genio ® system for the treatment of patients with moderate to severe obstructive sleep apnea (OSA) with an apnea-hypopnea index (AHI) of ...